Clinical Trial Update: Longitudinal Biomarkers With Selected Outcome Measures In CMT

View source ↗

Summary

A recruiting clinical trial aims to investigate longitudinal biomarkers and selected outcome measures in Charcot-Marie-Tooth disease, including CMT1A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Charcot-marie-tooth Disease
• Charcot-marie-tooth Disease Type 1a

Snippet

Sponsor: University Medical Center Goettingen | Conditions: CMT1A, CMT (Charcot Marie Tooth Disease) | Status: RECRUITING